Avandia is used to treat "type-2" or "adult-onset" diabetes. In 2007, the U.S. Food and Drug Administration (FDA) announced that Avandia and a number of other diabetes drugs would carry "black box" warnings on the risk of heart failure associated with use of the drugs. This section contains health and legal information on Avandia (generic name rosiglitazone).
- Senate Report: Grave Concerns over Avandia, FDA
- More Studies Link Avandia to Heart Risk
- FDA Hearing on Safety of Avandia
- Heart Attack Risk Added to Avandia Labeling
- Diabetes Drug Linked to Heart Disease
- Search for Avandia blog posts...
FindLaw Blog Posts:
- Are Avandia Litigants Closer to Recovery?
FindLaw KnowledgeBase Articles:
- Avandia Basics and Health Information
- Long-term Risk of Cardiovascular Events With Avandia (Rosiglitazone) Journal of the American Medical Association
- New England Journal of Medicine Study on Avandia
- FDA Announcement on "Black Box" Warning for Avandia
- FDA Safety Alert on Avandia
- FDA Information on Avandia